Temporary left ventricular assist device for complete recovery from reversible acute heart failure due to tumor necrosis factor-α inhibitor

Temporary left ventricular assist device for complete recovery from reversible acute heart failure due to tumor necrosis factor-α inhibitor

Bibliographic Details
Main Authors:	Marie-Camille Soucy-Giguere, Éric Charbonneau, Alexandre Cinq Mars, Michelle Dubois, Mario Sénéchal
Format:	Article
Language:	English
Published:	KARE Publishing 2019-06-01
Series:	Anatolian Journal of Cardiology
Subjects:	heart failure tnf-alpha inhibitors toxicity lvad
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-67124

Similar Items

Combined mechanical circulatory support for ventricular fibrillation in left ventricular assist device patient
by: Mahmood Abu Akel, et al.
Published: (2022-10-01)

Left Ventricular Assist Device Implantation in a Patient with Ventricular Pseudoaneurysm
by: Dejan Radakovic, et al.
Published: (2022-01-01)

Hyperpolypharmacy is a predictor of mortality after left ventricular assist device (LVAD) implantation
by: Lauren Dautzenberg, et al.
Published: (2022-12-01)

Total Joint Arthroplasty in Patients With an Implanted Left Ventricular Assist Device
by: John H. Rosenberg, MD, et al.
Published: (2023-02-01)

Latent Tuberculosis Infection and Tuberculosis Development in Children Treated with Anti-TNF-α Agents
by: Aykut EŞKİ, et al.
Published: (2023-07-01)

Durable Left Ventricular Assist Device Outflow Graft Obstructions: Clinical Characteristics and Outcomes
by: Carli J. Peters, et al.
Published: (2023-03-01)

Successful conservative management of left ventricular assist device candidates
by: Ofer Havakuk, et al.
Published: (2023-02-01)

Tumor necrosis factor-α in human American tegumentary leishmaniasis
by: Alda Maria Da-Cruz, et al.
Published: (1996-04-01)

Evaluation of tumor necrosis factor-α (TNF-α) levels in plasma and their correlation with periodontal status in obese and non-obese subjects
by: Khanna Suruchi, et al.
Published: (2010-01-01)

Cellular and Molecular Mechanisms Activated by a Left Ventricular Assist Device
by: Antonella Galeone, et al.
Published: (2023-12-01)

Oral milrinone for management of refractory right ventricular failure in patients with left ventricular assist devices
by: Waqas Akhtar, et al.
Published: (2022-12-01)

Left Ventricular Assist Device Pump Obstruction Reduces Native Heart Efficiency
by: Ricardo Montes, et al.
Published: (2023-12-01)

Self‐care behaviours of patients with left ventricular assist devices in Israel: changes during the COVID‐19 pandemic
by: Semyon Melnikov, et al.
Published: (2023-08-01)

Outflow graft obstruction after left ventricular assist device implantation: a retrospective, single‐centre case series
by: Akanksha Agrawal, et al.
Published: (2021-06-01)

Incremental cost-effectiveness of extracorporeal membranous oxygenation as a bridge to cardiac transplant or left ventricular assist device placement in patients with refractory cardiogenic shockCentral MessagePerspective
by: Joseph Reza, MD, et al.
Published: (2022-09-01)

Right and left ventricular assist devices are an option for bridge to heart transplantCentral MessagePerspective
by: Yaron D. Barac, MD, PhD, et al.
Published: (2022-03-01)

Biomarkers in Patients with Left Ventricular Assist Device: An Insight on Current Evidence
by: Carlotta Sciaccaluga, et al.
Published: (2022-02-01)

Flow mediated dilation in patient with Berlin Heart Incor left ventricle assist device
by: Franco Tarro Genta, et al.
Published: (2016-01-01)

The History of Durable Left Ventricular Assist Devices and Comparison of Outcomes: HeartWare, HeartMate II, HeartMate 3, and the Future of Mechanical Circulatory Support
by: Cecilia Berardi, et al.
Published: (2022-04-01)

Echocardiographic imaging and ventricular mechanics in pulsatile-flow LVAD pediatric patients: a systematic approach
by: R. Iacobelli, et al.
Published: (2024-01-01)

Calcium channel blockers and clinical outcomes in patients with continuous‐flow left ventricular assist devices
by: Hongtao Tie, et al.
Published: (2024-02-01)

Body mass index and natriuretic peptides trends before and after left ventricular assist device
by: Jessica Schultz, et al.
Published: (2023-01-01)

Effect of levosimendan infusion prior to left ventricular assist device implantation on right ventricular failure
by: Amitai Segev, et al.
Published: (2022-06-01)

Hemocompatibility-related Adverse Events Following HeartMate II Left Ventricular Assist Device Implantation between Japan and United States
by: Teruhiko Imamura, et al.
Published: (2020-03-01)

Left Ventricular Assist Device Implantation in Cancer-Therapy-Related Heart Failure
by: Johanna Mulzer, et al.
Published: (2022-09-01)

Platelet activation and aggregation in different centrifugal-flow left ventricular assist devices
by: Maximilian Tscharre, et al.
Published: (2022-02-01)

Diastolic Plateau – Invasive Hemodynamic Marker of Adverse Outcome Among Left Ventricular Assist Device Patients
by: Avishay Grupper, et al.
Published: (2022-04-01)

The dominant left ventricular assist device: lessons from an era
by: Amit Alam, et al.
Published: (2021-12-01)

Impact of Pre-Operative Right Ventricular Response to Hemodynamic Optimization on Outcomes in Patients with LVADs
by: Ernesto Ruiz Duque, et al.
Published: (2022-10-01)

Mechanistic assessment and ablation of left ventricular assist device related ventricular tachycardia in patients with severe heart failure
by: Felix Hohendanner, et al.
Published: (2023-04-01)

Significance of right ventricular function for the outcome of treatment and remodeling of the heart after left ventricular assist device implantation
by: Terzić Duško, et al.
Published: (2022-01-01)

Heart Failure Association of the European Society of Cardiology position paper on the management of left ventricular assist device‐supported patients for the non‐left ventricular assist device specialist healthcare provider: Part 2: at the emergency department
by: Davor Milicic, et al.
Published: (2021-12-01)

Safe Placement of Temporary Left Ventricular Assist Device Using Monitored Anesthesia Care and Regional Anesthesia in Patients With Cardiogenic Shock
by: John DePaolo, MD, PhD, et al.
Published: (2023-11-01)

Long-term safety and efficacy of anti-tumor necrosis factor-alpha biosimilar agents in the treatment of psoriasis: a single center study
by: Federica Ricceri, et al.
Published: (2022-05-01)

Full-scale numerical simulation of hemodynamics based on left ventricular assist device
by: Xinyi Gao, et al.
Published: (2023-05-01)

Tumour necrosis factor-α (TNF-α) in mycotic aborted placenta : an evaluation by Immunohistochemistry
by: Hameed A. Altememi
Published: (2019-06-01)

Erectile dysfunction and quality of life in patients under left ventricular assist device support − an unspoken issue
by: Aiste Monika Jakstaite, et al.
Published: (2023-10-01)

Cardiac mechanics and reverse remodelling under mechanical support from left ventricular assist devices
by: Blanca Pamias-Lopez, et al.
Published: (2023-08-01)

Impact of preoperative versus postoperative dialysis on left ventricular assist device outcomes: An analysis from the Society of Thoracic Surgeons Interagency Registry for Mechanically Assisted Circulatory Support databaseCentral MessagePerspective
by: J. Hunter Mehaffey, MD, MSc, et al.
Published: (2022-03-01)

Epidemiology and Risk Factors for Nosocomial Infections in Left Ventricular Assist Device Recipients
by: Simone Mornese Pinna, et al.
Published: (2024-02-01)